| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP,General Counsel, Secretary | EVP &General Counsel
1 company
Kim Austin D. is an EVP,General Counsel, Secretary at ACADIA PHARMACEUTICALS INC. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $1.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 8, 2024 | ACAD Acadia Pharmaceuticals Inc | EVP,General Counsel, Secretary | Sale+OE | 590 | $29.96 | $17,676.40 | -1.2% | -40.9% | -42.3% | |
| Oct 6, 2023 | ACAD Acadia Pharmaceuticals Inc | EVP,General Counsel, Secretary | Sale+OE | 16,369 | $21.96 | $359,463.24 | -26.3% | +38.1% | -30.4% | |
| May 1, 2023 | ACAD Acadia Pharmaceuticals Inc | EVP,General Counsel, Secretary | Sale+OE | 917 | $21.18 | $19,422.06 | -3.5% | +34.4% | -23.2% | |
| Apr 6, 2023 | ACAD Acadia Pharmaceuticals Inc | EVP,General Counsel, Secretary | Sale+OE | 1,456 | $18.16 | $26,440.96 | -5.9% | +31.7% | -1.9% | |
| Feb 24, 2023 | ACAD Acadia Pharmaceuticals Inc | EVP,General Counsel, Secretary | Sale+OE | 803 | $18.78 | $15,080.34 | -3.8% | +29.2% | +31.0% | |
| Jan 9, 2023 | ACAD Acadia Pharmaceuticals Inc | EVP,General Counsel, Secretary | Sale+OE | 589 | $17.13 | $10,089.75 | -3.1% | +5.6% | +81.9% | |
| May 2, 2022 | ACAD Acadia Pharmaceuticals Inc | EVP,General Counsel, Secretary | Sale+OE | 894 | $18.18 | $16,254.71 | -5.1% | -27.8% | +9.4% | |
| Feb 23, 2022 | ACAD Acadia Pharmaceuticals Inc | EVP &General Counsel | Sale+OE | 782 | $23.80 | $18,611.60 | -5.1% | -35.3% | -22.6% | |
| Jan 6, 2022 | ACAD Acadia Pharmaceuticals Inc | EVP &General Counsel | Sale+OE | 574 | $23.05 | $13,230.70 | -4.2% | +16.4% | -26.0% | |
| Apr 30, 2021 | ACAD Acadia Pharmaceuticals Inc | EVP &General Counsel | Sale+OE | 1,054 | $20.33 | $21,427.82 | -8.5% | +8.4% | -10.3% |